Patients Europe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patients europe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patients Europe Today - Breaking & Trending Today

European Commission Approves Pfizer's ELREXFIO® for Relapsed and Refractory Multiple Myeloma -December 08, 2023 at 07:56 am EST

Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial

ELREXFIO is an off-the-shelf ,. ....

United Kingdom , Al Hamed , Chris Boshoff , Myeloma Research Foundation , Pfizer Inc , Exchange Commission , Healthcare Products Regulatory Agency , End Results Program , Drug Administration , Approval Program , Committee For Medicinal Products Human Use , National Cancer Institute , European Medicines Agency , European Commission , Oncology Research , World Health Organization , Chief Oncology Research , Development Officer , Executive Vice President , Medicinal Products , Human Use , Accelerated Approval Program , Project Orbis , United Kingdom Medicines , Medicine Designation , Innovation Passport ,

European Commission Approves Pfizer's ELREXFIO for Relapsed and Refractory Multiple Myeloma

08.12.2023 - Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has granted conditional marketing authorization for ELREXFIO (elranatamab). ELREFXIO is a targeted immunotherapy for the treatment of adult patients with relapsed and refractory . ....

United Kingdom , Al Hamed , Exchange Commission , Approval Program , Drug Administration , European Commission , National Cancer Institute , Myeloma Research Foundation , World Health Organization , End Results Program , Healthcare Products Regulatory Agency , European Medicines Agency , Committee For Medicinal Products Human Use , Medicinal Products , Human Use , Accelerated Approval Program , Project Orbis , United Kingdom Medicines , Healthcare Products , Regulatory Agency , Medicine Designation , Innovation Passport , Mitigation Strategy , Wallet Card , Prescribing Information , Pfizer Oncology ,

Innovative cancer diagnostics must be seen as investment, says patient group chief

Innovative cancer diagnostics must be seen as investment, says patient group chief
euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Antonella Cardone , European Commission , Cancer Cell International , European Union , Cancer Patients Europe , Patients Europe , Eastern European , Western Europe , Commission President Ursula , Cancer Plan , Beating Cancer Plan ,

24% of patients will wait 5 months or more to get a myeloma diagnosis

24% of patients will wait 5 months or more to get a myeloma diagnosis Brussels, 27 September 2023 – Today is European Myeloma Day, a date to raise awareness about the most important issues for European myeloma patients. The findings of a recent report developed by Myeloma Patients Europe (MPE) are the dri. ....

Bruxelles Capitale , Paula Rocha , Vince Claus , Lise Lott Eriksson , Katie Joyner , Kate Morgan , European Myeloma Day , Myeloma Patients Europe , Myeloma Diagnosis Pathway , Co Chief Executive Officer , Diagnosis Pathway , Myeloma Diagnosis Across Europe , Diagnosis Experiences , European Myeloma Patientsand Perspectives , Lott Eriksson , Chief Executive Officer , Blood Cancer Awareness Month , Patients Europe ,

Burgeoning Immunotherapy Options in Oncology Move Beyond CAR T and the Usual Disease States

The use of immune therapies for hematological malignancies is expanding beyond chimeric antigen receptor (CAR) T-cell therapies in the traditional lymphoid disease states, but the impact on patient quality of life must remain top of mind, according to speakers at the European Hematology Association 2023 Congress. ....

Hermann Einsele , Hans Scheurer , Karolinska Institutet , Emma Morris , Stephan Mielke , Workgroup Of European Cancer Patient Advocacy Networks , University College London , European Hematology Association , Professor Emma Morris , University College , Professor Stephan Mielke , European Cancer Patient Advocacy , Patients Europe ,